Updated Remedent, Inc. Teleconference Information for Replay of Conference Call Held on Thursday, February 18, 2010
20 February 2010 - 7:33AM
Marketwired
Remedent, Inc. (OTCBB: REMI), an international company specializing
in the research, development, and manufacturing of oral care and
cosmetic dentistry products, announced the current information for
the replay of the conference call held on February 18, 2010.
Teleconference Replay Information
A telephone replay of the call is available until March 17,
2010. Toll-free replay number: 1-800-839-5490 International replay
number: 1-402-220-2550 (No passcode required)
About Remedent
Remedent, Inc. specializes in the research, development,
manufacturing and marketing of oral care and cosmetic dentistry
products. The company serves professional dental industry with
breakthrough technology for dental veneers, bridges and crowns that
are recognized worldwide for their technological superiority and
ease-of-application. These products are supported by a line of
professional veneer whitening and teeth sensitivity solutions.
Headquartered in Belgium, Remedent distributes its products to more
than 35 countries worldwide. For more information, go to
www.remedent.com.
Statement under the Private Securities
Litigation Reform Act of 1995
Statements in this press release that are "forward-looking
statements" are based on current expectations and assumptions that
are subject to risks and uncertainties. Such forward-looking
statements involve known and unknown risks, uncertainties and other
unknown factors that could cause Remedent's actual operating
results to be materially different from any historical results or
from any future results expressed or implied by such
forward-looking statements. In addition to statements that
explicitly describe these risks and uncertainties, readers are
urged to consider statements that contain terms such as "believes,"
"belief," "expects," "expect," "intends," "intend," "anticipate,"
"anticipates," "plans," "plan," "projects," "project," to be
uncertain and forward-looking. Actual results may differ materially
because of such risks and uncertainties and the reported results
should not be considered as an indication of future performance.
For further information regarding risks and uncertainties
associated with Remedent's business, please refer to the risk
factors described in Remedent's filings with the Securities and
Exchange Commission, including, but not limited to, its annual
report on Form 10-K and quarterly reports on Form 10-Q.
Company Contact: Stephen Ross Chief Financial Officer Remedent,
Inc. Tel 310-922-5685 docktor99@aol.com
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024